For: | Sim W, Lim WM, Hii LW, Leong CO, Mai CW. Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases. World J Gastroenterol 2022; 28(18): 1934-1945 [PMID: 35664961 DOI: 10.3748/wjg.v28.i18.1934] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i18/1934.htm |
Number | Citing Articles |
1 |
Songyu Guo, Zhenxia Wang. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1349308
|
2 |
Chin-King Looi, Lian-Chee Foong, Felicia Fei-Lei Chung, Alan Soo-Beng Khoo, Ee-Mun Loo, Chee-Onn Leong, Chun-Wai Mai. Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancer. Cell Biology and Toxicology 2023; 39(6): 2501 doi: 10.1007/s10565-023-09830-9
|
3 |
Zheng Wu, Ze-Xuan Fang, Yan-Yu Hou, Bing-Xuan Wu, Yu Deng, Hua-Tao Wu, Jing Liu. Review of ferroptosis in colorectal cancer: Friends or foes?. World Journal of Gastroenterology 2023; 29(3): 469-486 doi: 10.3748/wjg.v29.i3.469
|
4 |
Yuen-Fen Tan, Ling-Wei Hii, Wei-Meng Lim, Soon-Keng Cheong, Chee-Onn Leong, Maxine Swee-Li Yee, Chun-Wai Mai. Polyethylene glycol-phospholipid functionalized single-walled carbon nanotubes for enhanced siRNA systemic delivery. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-80646-1
|
5 |
Yuxia Wu, Xiangyan Jiang, Zeyuan Yu, Zongrui Xing, Yong Ma, Huiguo Qing. Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms. Recent Patents on Anti-Cancer Drug Discovery 2025; 20(1): 1 doi: 10.2174/0115748928269276231120103256
|
6 |
Jian Hong, Saber Y. Adam, Shiqi Wang, Hao Huang, In Ho Kim, Abdelkareem A. Ahmed, Hao-Yu Liu, Demin Cai. Melatonin Modulates ZAP70 and CD40 Transcripts via Histone Modifications in Canine Ileum Epithelial Cells. Veterinary Sciences 2025; 12(2): 87 doi: 10.3390/vetsci12020087
|
7 |
Sophia Ogechi Ekeuku, Effiong Paul Etim, Kok-Lun Pang, Kok-Yong Chin, Chun-Wai Mai. Vitamin E in the management of pancreatic cancer: A scoping review. World Journal of Gastrointestinal Oncology 2023; 15(6): 943-958 doi: 10.4251/wjgo.v15.i6.943
Abstract(672) |
Core Tip(581) |
Full Article(HTML)(2011)
|
Full Article with Cover (PDF)-1316K(124)
|
Full Article (Word)-652K(44)
|
Audio-232K(9)
|
Peer-Review Report-285K(66)
|
Answering Reviewers-200K(69)
|
Full Article (PDF)-1012K(183)
|
Full Article (XML)-221K(104)
|
Times Cited (6)
|
Total Visits (5521)
|
Open
|
8 |
Lei Jin, Daohai Qian, Xiaolei Tang, Yong Huang, Junwei Zou, Zhaoying Wu. SMYD2 Imparts Gemcitabine Resistance to Pancreatic Adenocarcinoma Cells by Upregulating EVI2A. Molecular Biotechnology 2024; 66(10): 2920 doi: 10.1007/s12033-023-00908-7
|
9 |
Chin-King Looi, Li-Lian Gan, Wynne Sim, Ling-Wei Hii, Felicia Fei-Lei Chung, Chee-Onn Leong, Wei-Meng Lim, Chun-Wai Mai. Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic Cancer. Cancers 2022; 14(15): 3709 doi: 10.3390/cancers14153709
|
10 |
Yijia Tang, Guangzu Cui, Haicong Liu, Ying Han, Changjing Cai, Ziyang Feng, Hong Shen, Shan Zeng. Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells. Cancer Communications 2024; 44(6): 601 doi: 10.1002/cac2.12546
|
11 |
Mihaela Andreescu. Epigenetic Alterations That Are the Backbone of Immune Evasion in T-cell Malignancies. Cureus 2024; doi: 10.7759/cureus.51662
|
12 |
Jie Xu, Yaomei Tian, Die Hu, Xi Yan, Li Yang. Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges. MedComm – Oncology 2024; 3(3) doi: 10.1002/mog2.85
|
13 |
Zeynep Akpınar, Nilgün Gürbüz. Carvacrol is a Novel Natural Therapeutic Approach Through the Inhibition of Proliferation, Autophagy and Migration in Pancreatic Ductal Adenocarcinoma Cells. SDÜ Tıp Fakültesi Dergisi 2024; doi: 10.17343/sdutfd.1560561
|
14 |
Renzo Vera, María Julia Lamberti, Alina L. Gonzalez, Martín E. Fernandez-Zapico. Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer. Pancreatology 2024; 24(6): 878 doi: 10.1016/j.pan.2024.07.005
|